Group G streptococcal bacteremia and de novo hepatocellular carcinoma after liver transplantation.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 12037793)

Published in Liver Transpl on June 01, 2002

Authors

Josh Levitsky, Thomas W Faust, Stanley M Cohen, Helen S Te

Articles by these authors

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med (2005) 4.27

An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med (2014) 3.04

Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases. Liver Transpl (2007) 2.31

Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl (2008) 2.30

National survey of provider opinions on controversial characteristics of liver transplant candidates. Liver Transpl (2013) 2.00

Female mouse fetal loss mediated by maternal autoantibody. J Exp Med (2012) 1.92

Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl (2003) 1.64

Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol (2011) 1.62

A case of adult hepatic toxocariasis. Nat Clin Pract Gastroenterol Hepatol (2008) 1.51

Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy. Liver Transpl (2014) 1.50

Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. J Hepatol (2009) 1.50

National survey of adult transplant hepatologists on the pediatric-to-adult care transition after liver transplantation. Liver Transpl (2015) 1.41

Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty (2005) 1.15

Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause (2004) 1.05

Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology (2012) 1.03

Magnetic resonance elastography and biomarkers to assess fibrosis from recurrent hepatitis C in liver transplant recipients. Transplantation (2011) 0.97

Overview of immunosuppression in liver transplantation. World J Gastroenterol (2009) 0.96

Genomic biomarkers correlate with HLA-identical renal transplant tolerance. J Am Soc Nephrol (2013) 0.94

A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. Dis Colon Rectum (2005) 0.93

Epstein-barr virus: an unusual cause of cholestatic hepatitis in older adults. Gastroenterol Hepatol (N Y) (2007) 0.92

Duplex Doppler ultrasound of the hepatic artery in patients with acute alcoholic hepatitis. J Clin Gastroenterol (2002) 0.91

The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl (2003) 0.91

Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver Transpl (2015) 0.90

Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study. Transplantation (2015) 0.88

Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation (2010) 0.88

The safety and outcome of joint replacement surgery in liver transplant recipients. Liver Transpl (2003) 0.87

An overview of solid organ transplantation. Clin Chest Med (2005) 0.85

Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data. Liver Transpl (2011) 0.84

Persistent spontaneous bacterial peritonitis: a common complication in patients with spontaneous bacterial peritonitis and a high score in the model for end-stage liver disease. Therap Adv Gastroenterol (2012) 0.84

A case of biliopleural fistula in a patient with hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2009) 0.84

Acid-base and potassium disorders in liver disease. Semin Nephrol (2006) 0.83

Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease. J Clin Gastroenterol (2014) 0.82

MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplants. Acad Radiol (2012) 0.82

Hepatotoxicity and drug interactions in liver transplant candidates and recipients. Clin Liver Dis (2013) 0.82

Portal flow and arterioportal shunting after transjugular intrahepatic portosystemic shunt creation. J Vasc Interv Radiol (2006) 0.82

Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation (2012) 0.82

High early cardiovascular mortality after liver transplantation. Liver Transpl (2014) 0.82

Association of hepatic artery stenosis and biliary strictures in liver transplant recipients. Liver Transpl (2011) 0.82

Glycemic control by a glucose management service and infection rates after liver transplantation. Endocr Pract (2011) 0.81

The current state and future prospects of chronic hepatitis C virus infection treatment. Curr Infect Dis Rep (2014) 0.81

Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR. PLoS One (2011) 0.78

Transjugular intrahepatic portosystemic shunt with thrombectomy for the treatment of portal vein thrombosis after liver transplantation. Dig Dis Sci (2009) 0.78

Simulation modeling of the impact of proposed new simultaneous liver and kidney transplantation policies. Transplantation (2015) 0.78

Multiphase Multi-Detector Row Computed Tomography Imaging Characteristics of Large (>5 cm) Focal Hepatocellular Carcinoma. J Comput Assist Tomogr (2016) 0.78

The renal benefit of mycophenolate mofetil after liver transplantation. Clin Transplant (2010) 0.78

Meeting report of the 19th Annual International Congress of the International Liver Transplantation Society (Sydney Convention and Exhibition Centre, Sydney, Australia, June 12-15, 2013). Liver Transpl (2013) 0.78

HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance. Clin Transpl (2013) 0.78

Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study. Exp Clin Transplant (2016) 0.77

Varicella infection following varicella vaccination in a liver transplant recipient. Am J Transplant (2002) 0.77

Haploidentical hematopoietic stem cell transplantation for graft-versus-host disease after liver transplantation. Blood (2011) 0.77

Mycophenolate mofetil monotherapy in liver transplant recipients. Clin Transplant (2011) 0.76

A case of complete resolution of gastric varices. Nat Rev Gastroenterol Hepatol (2009) 0.75

New models to enhance the assessment of mortality risk in low model for end-stage liver disease patients: "objectifying" the subjective. Liver Transpl (2014) 0.75

To kidney or not to kidney, when … is the question. Liver Transpl (2012) 0.75

Reply: To PMID 23197388. Liver Transpl (2014) 0.75

Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy): A Nurse-Driven Evidence-Based Protocol. Gastroenterol Nurs (2015) 0.75

The impact of coronary artery disease on outcomes after liver transplantation. J Cardiovasc Med (Hagerstown) (2016) 0.75

INPATIENT HYPOGLYCEMIC EVENTS IN A COMPARATIVE EFFECTIVENESS TRIAL FOR GLYCEMIC CONTROL IN A HIGH-RISK POPULATION. Endocr Pract (2016) 0.75

Paraesophageal hernia: a rare presentation of Marfan syndrome in adults. Gastrointest Endosc (2007) 0.75

Chronic rejection related to hepatitis B immunoglobulin discontinuation in a liver transplant recipient. Transpl Int (2011) 0.75

Report of the 22nd Annual Congress of the International Liver Transplantation Society. Transplantation (2016) 0.75

Delayed Donor Bone Marrow Infusion Induces Liver Transplant Tolerance. Transplantation (2017) 0.75

Find it in your heart. Liver Transpl (2013) 0.75

Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease. Inflamm Bowel Dis (2004) 0.75

Liver Transplantation in the Obese Cirrhotic Patient. Transplantation (2017) 0.75